Browse Results

  • Principal Investigator: Lekakis, Lazaros


There are 4 clinical trial(s) matching your criteria.

Back

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Entospletinib, a Selective SYK Inhibitor, in Combination with Systemic Corticosteroids as First-Line Therapy in Subjects with Chronic Graft Versus Host Disease (cGVHD)

Investigator: Lazaros Lekakis

Institutional Protocol #: 20160645

National Clinical Trials Identifier: NCT02701634

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase II

Enrolling Since: 2/3/2017

Back